Xenotherapeutics Inc
- Assets
- $593.1k
- Revenue
- $990.1k
- Investments
- $0.0
- Employees
- 0
- Location
- Boston, MA
- Founding
- 10/2018
- Data as of
- 12/2022
- EIN
- 81-1016095
Organization Overview
Xenotherapeutics Inc is located in Boston, MA. The organization was established in 2018. According to its NTEE Classification (G80) the organization is classified as: Specifically Named Diseases, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Xenotherapeutics Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Xenotherapeutics Inc generated $990.1k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 4 years, the organization has seen revenues fall by an average of (6.8%) each year. All expenses for the organization totaled $1.0m during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (4.7%) per year over the past 4 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
Part 3 - Line 4a
CLINICAL TRIAL: THE FOUNDATION CONTINUED TO CONDUCT THE FIRST IN-HUMAN, CLINICAL TRIALS OF LIVE-CELL, NONHUMAN ORGAN TRANSPLANTS. THE END-GOAL FOR THIS RESEARCH IS TO DEVELOP AND PRODUCE TRANSPLANTS AND PRODUCTS TO TREAT SEVERE BURNS. THE ORGANIZATION'S PRESIDENT & CEO IS LARGELY RESPONSIBLE FOR RUNNING AND MANAGING THE CLINICAL TRIALS, ALONG WITH THE ASSISTANCE OF VOLUNTEER AND OUTSIDE-CONTRACTED SCIENTISTS.
SWINE HERD DEVELOPMENT & MATERIAL PROCUREMENT: THE FOUNDATION ENGAGED IN ANIMAL HUSBANDRY AND THE PROCUREMENT OF GENETICALLY ENGINEERED SWINE DONORS IN ACCORDANCE WITH FDA STANDARDS. THE FOUNDATION INTENDS FOR ITS RESEARCH AND PROGRESS IN ANIMAL HUSBANDRY AND ANIMAL ORGAN-DEVELOPMENT TO IMPROVE THE COMPATIBILITY BETWEEN PATIENTS AND ORGAN-DONORS.
EDUCATION: THE FOUNDATION CONTINUED TO ADVANCE PUBLIC EDUCATION AND KNOWLEDGE ABOUT XENOTRANSPLANTATION AND ITS POSSIBLE APPLICATIONS. EDUCATIONAL RESOURCES WERE PROVIDED THROUGH THE FOUNDATION'S WEBSITE, MEETINGS, CONFERENCES, AND OTHER SIMILAR MEDIUMS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Jon Adkins President & CEO | 40 | $250,000 | |
Jamie Love Treasurer & CFO | 40 | $62,500 | |
William Deacon Chairman | 15 | $0 | |
Dr Dicken Ko Clerk | 15 | $0 | |
Mark Nedelman Trustee | 15 | $0 | |
Ruta Laukien Trustee | 15 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Statking Clinical Services | 12/30/22 | $67,599 |
Massachusetts General Hospital | 12/30/22 | $53,879 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $421 |
| Interest on Savings | $0 |
| Dividends & Interest | $0 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $0 |
| Capital Gain Net Income | $0 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $989,665 |
| Total Revenue | $990,086 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $325,000 |
| Other employee salaries and wages | $26,955 |
| Pension plans, employee benefits | $20,681 |
| Interest | $24,138 |
| Taxes | $0 |
| Depreciation | $53,882 |
| Occupancy | $70,070 |
| Travel, conferences, and meetings | $14,487 |
| Printing and publications | $12,501 |
| Other expenses | $482,513 |
| Total operating and administrative expenses | $1,042,957 |
| Contributions, gifts, grants paid | $0 |
| Total expenses and disbursements | $1,042,957 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $30,519 |
| Savings and temporary cash investments | $0 |
| Net Accounts receivable | $36,984 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $525,639 |
| Other assets | $0 |
| Total assets | $593,142 |
| Accounts payable and accrued expenses | $267,317 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $40,000 |
| Mortgages and other notes payable | $228,745 |
| Other liabilities | $160,898 |
| Total liabilities | $696,960 |